Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple‐negative breast cancer: Results from the triple‐negative breast cancer cohort of the phase 2 LE... von Chung, Hyun Cheol, Saada‐Bouzid, Esma, Longo, Federico, Yanez, Eduardo, Im, Seock‐Ah, Castanon, Eduardo, Desautels, Danielle N., Graham, Donna M., Garcia‐Corbacho, Javier, Lopez, Juanita, Dutcus, Corina, Okpara, Chinyere E., Ghori, Razi, Jin, Fan, Groisberg, Roman, Korakis, Iphigenie

Volltext

Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study von González-Martín, Antonio, Chung, Hyun Cheol, Saada-Bouzid, Esma, Yanez, Eduardo, Senellart, Helene, Cassier, Philippe A., Basu, Bristi, Corr, Bradley R., Girda, Eugenia, Dutcus, Corina, Okpara, Chinyere E., Ghori, Razi, Jin, Fan, Groisberg, Roman, Lwin, Zarnie

Volltext

Abstract PS12-07: Lenvatinib plus pembrolizumab for previously treated, advanced triple-negative breast cancer: Early results from the multicohort phase 2 LEAP-005 study von Chung, Hyun Cheol, Saada-Bouzid, Esma, Muñoz, Federico Longo, Yanez, Eduardo, Im, Seock-Ah, Castanon, Eduardo, Graham, Donna M., Garcia-Corbacho, Javier, Lopez, Juanita, Ghori, Razi, Dutcus, Corina, Smith, Alan, Norwood, Kevin, Gomez-Roca, Carlos

Volltext

LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort von Chung, Hyun Cheol Cheol, Lwin, Zarnie, Gomez-Roca, Carlos A., Longo, Federico, Yanez, Eduardo, Castanon Alvarez, Eduardo, Graham, Donna M., Doherty, Mark, Cassier, Philippe, Lopez, Juanita Suzanne, Basu, Bristi, Hendifar, Andrew Eugene, Maurice-Dror, Corinne, Gill, Sanjeev Singh, Ghori, Razi, Kubiak, Peter, Jin, Fan, Norwood, Kevin Glen, Saada-Bouzid, Esma

Volltext

LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort von Chung, Hyun Cheol, Lwin, Zarnie, Gomez-Roca, Carlos, Longo, Federico, Yanez, Eduardo, Castanon Alvarez, Eduardo, Graham, Donna, Doherty, Mark, Cassier, Philippe, Lopez, Juanita Suzanne, Basu, Bristi, Hendifar, Andrew Eugene, Maurice-Dror, Corinne, Gill, Sanjeev Singh, Ghori, Razi, Kubiak, Peter, Jin, Fan, Norwood, Kevin Glen, Saada-Bouzid, Esma

Volltext

Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study von Tanoglu, Alpaslan, Erdem, Hakan, Friedland, Jon S., Ankaralı, Handan, Garcia-Goez, Jose Fernando, Albayrak, Ayse, El-Kholy, Amani, Ceviker, Sevil Alkan, Amer, Fatma, Erol, Serpil, Darazam, Ilad Alavi, Rabiei, Mohammad Mahdi, Sarwar, Muhammad Zeeshan, Zeb, Misbah, Nawaz, Hassan, Ceylan, Mehmet Resat, Cernat, Roxana, Tasbakan, Meltem, Ayoade, Folusakin, Ruch, Yvon, Tigen, Elif Tükenmez, Angioni, Goffredo, Rajani, Dhanji P., Akhtar, Nasim, Surme, Serkan, Sengoz, Gonul, Karlıdag, Gulden Eser, Marino, Andrea, Ripon, Rezaul Karim, Çağ, Yasemin, Aydın, Özlem, Akkoyunlu, Yasemin, Seyman, Derya, Angamuthu, Kumar, Cascio, Antonio, Popescu, Corneliu Petru, Sirmatel, Fatma, Eren, Esma, Dar, Razi Even, Munu, Foday Usman, Tanoglu, Esra Guzel, Echeverry, Esteban, Velez, Juan Diego, Artuk, Cumhur, Balin, Safak Ozer, Pandya, Nirav, Erdem, Aysegul, Demiray, Emine Kübra Dindar, Aypak, Adalet

Volltext